Transsphenoidal Surgery for Acromegaly: Endocrinological Follow-up of 98 Patients
暂无分享,去创建一个
[1] F. Casanueva,et al. Criteria for cure of acromegaly: a consensus statement. , 2000, The Journal of clinical endocrinology and metabolism.
[2] Clayton. How many surgeons to operate on acromegalic patients? , 1999, Clinical endocrinology.
[3] Stratton,et al. Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience , 1999, Clinical endocrinology.
[4] S. Wardlaw,et al. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. , 1998, The Journal of clinical endocrinology and metabolism.
[5] Davis,et al. The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma , 1998, Clinical endocrinology.
[6] P. Black,et al. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. , 1998, The Journal of clinical endocrinology and metabolism.
[7] K. Lamborn,et al. Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. , 1998, The Journal of clinical endocrinology and metabolism.
[8] S. Melmed,et al. Management of Pituitary Tumors , 1998, Annals of Internal Medicine.
[9] S. Wardlaw,et al. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. , 1998, Journal of neurosurgery.
[10] S. Melmed,et al. Current treatment guidelines for acromegaly. , 1998, The Journal of clinical endocrinology and metabolism.
[11] D. Lüdecke,et al. Recent results of secondary transnasal surgery for residual or recurring acromegaly. , 1998, Neurosurgery.
[12] H. Sandler,et al. Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. , 1997, The Journal of clinical endocrinology and metabolism.
[13] A. Grossman,et al. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure , 1996, Clinical endocrinology.
[14] J. Hardy,et al. Surgical outcome after repeated transsphenoidal surgery in acromegaly. , 1996, Journal of neurosurgery.
[15] S. Melmed,et al. Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly. , 1995, The Journal of clinical endocrinology and metabolism.
[16] P. Kendall‐Taylor,et al. Factors determining the long-term outcome of surgery for acromegaly. , 1994, QJM : monthly journal of the Association of Physicians.
[17] B. Scheithauer,et al. Results of surgical treatment for growth hormone-secreting pituitary adenomas. , 1993, Journal of neurosurgery.
[18] R. Clayton,et al. An audit of outcome of treatment in acromegaly. , 1993, The Quarterly journal of medicine.
[19] J. Honegger,et al. Surgical management of acromegaly. , 1992, Endocrinology and metabolism clinics of North America.
[20] D. Ross,et al. Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients. , 1988, Journal of neurosurgery.
[21] G. Palombarini. Future Meetings-Congress of Neurological Surgeons. , 2001, Neurosurgery.
[22] Ciric Ivan,et al. Complications of Transsphenoidal Surgery: Results of a National Survey, Review of the Literature, and Personal Experience. , 1997, Neurosurgery.
[23] S. Lamberts. Sandostatin® in the Treatment of Acromegaly , 1988, Springer Berlin Heidelberg.